GlassScriptPhysician profile
Jason M Young
NPI 1679004121
$3,155.58
in general payments reported to CMS, 2019-2025
21 companies · $348 in 2025
The $348 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $31.95 · 2022: $1,725 · 2023: $464 · 2024: $586 · 2025: $348.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,398.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,398.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Carl Zeiss Meditec USA, INC. | $1,567.35 | 2022 | |
| Alcon Vision LLC | $454.36 | 2022-2025 | Hydrus Microstent, Clareon |
| Abbvie INC. | $291.20 | 2023-2025 | Durysta, Vuity, Alphagan P |
| Ocular Therapeutix, INC. | $112.19 | 2022-2024 | Dextenza |
| Biotissue Holdings INC. | $93.00 | 2024-2025 | |
| Sight Sciences, INC. | $84.42 | 2021-2025 | Omni Surgical System, Sion Surgical Instrument |
| Mallinckrodt Hospital Products INC. | $70.37 | 2023-2024 | Acthar |
| Sun Pharmaceutical Industries INC. | $66.68 | 2022-2024 | Cequa |
| Rayner Intraocular Lenses Limited | $61.55 | 2022-2025 | Omidria |
| Johnson & Johnson Surgical Vision, INC. | $51.60 | 2023-2024 | Catalys System, Tecnis Iol, Tecnis Iol |
| Harrow Eye, LLC | $48.57 | 2024-2025 | Vevye, Iheezo |
| Oyster Point Pharma, INC. | $44.15 | 2022-2023 | Tyrvaya |
| Tarsus Pharmaceuticals, INC. | $37.33 | 2025 | Xdemvy |
| Bausch & Lomb Americas INC. | $36.00 | 2025 | Xiidra, Miebo |
| Glaukos Corporation | $33.61 | 2024 | Idose |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $20.84 | 2023 | |
| Allergan, INC. | $19.02 | 2022 | |
| Rxsight INC | $18.69 | 2024 | Rxsight Light Delivery Device (Ldd), Rxsight Contact Lens, Rxsight Injector Handpiece |
| Thea Pharma INC. | $17.96 | 2025 | Iyuzeh |
| Ivantis, INC | $17.70 | 2021 | |
| New World Medical,INC. | $8.99 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Young listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.